Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of PRO-087 in Healthy Subjects
NCT03524157Phase 1Completed
- Sponsor
- Laboratorios Sophia
- Start
- Jul 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Humylub Ofteno PF in dry eye syndrome (DED) (3 arms), sponsored by Laboratorios Sophia. Primary endpoint: Goblet Cell Density at Day 10. Started Jul 2017; status: completed.
02
Drugs
Humylub Ofteno PF
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03524157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524157.